Overview

Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fed Conditions

Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to prove the bioequivalence of Valacyclovir Hydrochlorothiazide Caplet under fed conditions.
Phase:
N/A
Details
Lead Sponsor:
Roxane Laboratories
Treatments:
Acyclovir
Valacyclovir